[1] Hell L, Wisgrill L, Ay C, et al. Procoagulant extracellular vesicles in amniotic fluid. Transl Res. 2017;184:12-20.e1.[2] Erez O. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2017;217(2):228-229. [3] Kobayashi H. Amniotic Fluid Embolism: Anaphylactic Reactions With Idiosyncratic Adverse Response. Obstet Gynecol Surv. 2015;70(8): 511-517.[4] 吴琦. IL-6、IL-8与羊水栓塞关系的实验研究[D]. 遵义:遵义医学院, 2014.[5] 岳艳, 刘伯毅. TNF-α、IL-1β及中性粒细胞凋亡在妊娠家兔羊水栓塞肺损伤中的作用[J]. 湖北医药学院学报, 2014,33(1): 4-6.[6] 谢同林,王方,谢成明, 等. MMP-9、TIMP-1在羊水栓塞大鼠模型的表达及意义[J].遵义医学院学报, 2016, 39(1):22-25.[7] 卢颖州,高谋. 孕鼠羊水栓塞补体C3、C4和B因子的动态变化及意义[J]. 中国妇产科临床杂志, 2014,15(3): 220-222.[8] 龙艳丽,胡勇,余舰,等. 孕兔羊水栓塞补体C3a、凝血功能的研究[J]. 遵义医学院学报, 2015, 38(2): 164-167.[9] McDonnell NJ, Percival V, Paech MJ. Amniotic fluid embolism: a leading cause of maternal death yet still a medical conundrum. Int J Obstet Anesth. 2013;22(4):329-336.[10] Lapinsky SE. Management of Acute Respiratory Failure in Pregnancy. Semin Respir Crit Care Med. 2017;38(2):201-207.[11] Clark SL. Amniotic fluid embolism. Obstet Gynecol. 2014;123 (2 Pt 1):337-348.[12] Zaami S, Marinelli E, Montanari Vergallo G. Assessing malpractice lawsuits for death or injuries due to amniotic fluid embolism. Clin Ter. 2017;168(3):e220-e224.[13] Erez O. Disseminated intravascular coagulation in pregnancy - Clinical phenotypes and diagnostic scores. Thromb Res. 2017; 151 Suppl 1:S56-S60.[14] Moaddab A, Klassen M, Priester CD, et al. Reproductive decisions after the diagnosis of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol. 2017;211:33-36.[15] Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management. J Obstet Gynaecol Res. 2014; 40(6):1507-1517.[16] 容晓莹,郭向阳,曾鸿,等. 术中回收式自体输血在产科患者中的应用[J]. 中国输血杂志, 2017, 30(1): 94-98.[17] Tamura N, Farhana M, Oda T, et al. Amniotic fluid embolism: Pathophysiology from the perspective of pathology. J Obstet Gynaecol Res. 2017;43(4):627-632.[18] Stanten RD, Iverson LI, Daugharty TM, et al. Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: diagnosis by transesophageal echocardiogram and treatment by cardiopulmonary bypass. Obstet Gynecol. 2003;102(3):496-498.[19] 周云秀. 羊水栓塞的高危诱因及地塞米松防治效果分析[J]. 医学理论与实践, 2017, 30(13): 1972-1974.[20] 陈晶. 地塞米松对产妇羊水栓塞的临床防治效果探究[J]. 当代医学, 2017, 23(22): 106-107.[21] Kramer MS, Abenhaim H, Dahhou M, et al. Incidence, risk factors, and consequences of amniotic fluid embolism. Paediatr Perinat Epidemiol. 2013;27(5):436-441.[22] Todo Y, Tamura N, Itoh H, et al. Therapeutic application of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism: a case report. Clin Case Rep. 2015;3(7):673-675.[23] 马凯. 对羊水栓塞本源性发生机制和有效治疗方法探讨[J]. 医学争鸣, 2017(2): 60-63.[24] Glem?ait? M, Navakauskien? R. Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes. Stem Cells Int. 2016;2016:6465307.[25] Ma J, Shen Y, Stojicic S, et al. Biocompatibility of two novel root repair materials. J Endod. 2011;37(6):793-798.[26] Zhang W, Li Z, Peng B. Effects of iRoot SP on mineralization-related genes expression in MG63 cells. J Endod. 2010;36(12):1978-1982.[27] Song J, Gao Y, Zhou WB, et al. Immunomodulatory effects of human amniotic versus bone marrow-derived mesenchymal stem cells on peripheral blood T lymphocytes in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37(6):780-785.[28] Zhang C, Yu L, Liu S, et al. Human amnion-derived mesenchymal stem cells promote osteogenic and angiogenic differentiation of human adipose-derived stem cells. PLoS One. 2017;12(10): e0186253.[29] Tancharoen W, Aungsuchawan S, Pothacharoen P, et al. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Acta Histochem. 2017;119(2):113-121.[30] Fanti M, Gramignoli R, Serra M, et al. Differentiation of amniotic epithelial cells into various liver cell types and potential therapeutic applications. Placenta. 2017;59:139-145. [31] 赵庆丽. 剖宫产发生羊水栓塞的临床分析[J]. 世界最新医学信息文摘, 2016, 16(45): 119,151.[32] Gan L, Duan H, Xu Q, et al. Human amniotic mesenchymal stromal cell transplantation improves endometrial regeneration in rodent models of intrauterine adhesions. Cytotherapy. 2017;19(5):603-616.[33] 强勇,梁贵友,余丽梅,等.人羊膜间充质干细胞移植减轻体外循环再灌注肺损伤[J].中国组织工程研究,2016,20(1):70-77.[34] Phermthai T, Thongbopit S, Pokathikorn P, et al. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies. Cytotherapy. 2017;19(8):990-1001.[35] 沈鑫.实验大鼠羊水栓塞与PAI-1、CPA3、ET-1的相关性研究[D].遵义:遵义医学院,2015.[36] Liu FB, Lin Q, Liu ZW. A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models. Eur Rev Med Pharmacol Sci. 2016;20(5):969-982.[37] Zhang S, Jiang W, Ma L, et al. Nrf2 transfection enhances the efficacy of human amniotic mesenchymal stem cells to repair lung injury induced by lipopolysaccharide.J Cell Biochem. 2017 Sep 14. doi: 10.1002/jcb.26322. [Epub ahead of print] [38] Fang X, Neyrinck AP, Matthay MA, et al. Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem. 2010;285(34):26211-26222.[39] Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses. 2007;68(5):1019-1025.[40] 刘圣. 人羊膜间充质干细胞对外周血T淋巴细胞的免疫调节作用及机制[D]. 遵义:遵义医学院, 2013.[41] 帅华洲. 人羊膜间充质干细胞对急性移植物抗宿主病影响的研究[D]. 昆明:昆明医科大学, 2016.[42] Baulier E, Favreau F, Le Corf A, et al. Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. Stem Cells Transl Med. 2014;3(7):809-820.[43] Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, et al. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study. BJOG. 2016;123(1):100-109. |